Muntz H G, Bell D A, Lage J M, Goff B A, Feldman S, Rice L W
Massachusetts General Hospital, Harvard Medical School, Boston.
Obstet Gynecol. 1992 Dec;80(6):935-9.
To assess the diagnostic accuracy of cervical conization in women with adenocarcinoma in situ and to determine whether a select group of women could be managed by conization alone without hysterectomy.
We retrospectively reviewed 40 cases of cervical adenocarcinoma in situ diagnosed on cervical conization.
Cervical conization revealed adenocarcinoma in situ alone in 15 women. Twenty-five women had adenocarcinoma in situ coexisting with squamous dysplasia (23) or microinvasive squamous cell carcinoma (two). Twenty-two women underwent hysterectomy after cone biopsy. Adenocarcinoma in situ was detected in the hysterectomy specimen in one of 12 women with uninvolved cone margins, versus seven of ten women with involved margins (P = .006); two of these seven women also had foci of invasive adenocarcinoma in the hysterectomy specimen. Conization was the only treatment for 18 selected women with adenocarcinoma in situ and uninvolved margins; all were relapse-free after a median interval of 3 years (range 1.5-5).
Women with cervical adenocarcinoma in situ diagnosed by conization who have positive margins are at high risk of residual adenocarcinoma in situ and moderate risk of occult invasive adenocarcinoma; expectant management is not warranted. However, a cone biopsy with uninvolved margins can reliably guide subsequent therapy. Selected young women who desire preservation of fertility and have uninvolved margins probably can be managed by conization alone, but further study is required to establish the safety of this approach.
评估宫颈锥切术对原位腺癌女性的诊断准确性,并确定是否有一部分女性仅通过锥切术而不进行子宫切除术即可得到治疗。
我们回顾性分析了40例经宫颈锥切术诊断为宫颈原位腺癌的病例。
宫颈锥切术显示15名女性仅患有原位腺癌。25名女性的原位腺癌与鳞状上皮发育异常(23例)或微浸润鳞状细胞癌(2例)并存。22名女性在锥切活检后接受了子宫切除术。在12名切缘未受累的女性中,有1名在子宫切除标本中检测到原位腺癌,而在10名切缘受累的女性中有7名检测到原位腺癌(P = .006);这7名女性中有2名在子宫切除标本中也有浸润性腺癌灶。对于18名切缘未受累的原位腺癌女性,锥切术是唯一的治疗方法;所有患者在中位间隔3年(范围1.5 - 5年)后均无复发。
经锥切术诊断为宫颈原位腺癌且切缘阳性的女性,残留原位腺癌风险高,隐匿性浸润性腺癌风险中等;不适合进行期待治疗。然而,切缘未受累的锥切活检可可靠地指导后续治疗。部分希望保留生育能力且切缘未受累的年轻女性可能仅通过锥切术即可得到治疗,但需要进一步研究以确定该方法的安全性。